
Dartrace completes USD22.5m Series B financing with Summit Partners
Darktrace has completed a USD22.5 million Series B with Summit Partners, a global growth equity investor. The round completes an exceptional growth year for Darktrace, with Talis Capital extending the Series A they led in March 2015, with a further USD1.8m prior to the Series B round. Darktrace’s Enterprise Immune



